Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
ThursdayFeb 16, 2017 9:37 am

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Uplists to the OTCQB Venture Market

Diversified holding company Player’s Network, Inc. (OTCQB: PNTV) this morning announced that its common shares are now trading on the OTCQB Venture Market, effective February 16, 2017. In order to be eligible for listing on the OTCQB Venture Market, which is designed for entrepreneurial and development-stage companies, Player’s Network was required to be current in its financial reporting and undergo an annual company verification and management certification process. “We are proud to announce this corporate milestone as we execute our plan to add tenure to our 23-year track record as a fully reporting company,” Mark Bradley, CEO of Player’s Network,…

Continue Reading

ThursdayFeb 16, 2017 9:24 am

NetworkNewsBreaks – ORhub, Inc. (ORHB) Announces Engagement of NetworkNewsWire

Health care software-as-a-service company ORhub, Inc. (OTC: ORHB) this morning announced that it has engaged NetworkNewsWire (NNW), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. As part of this new client-partner relationship, NNW will leverage its investor-based Brand Network of partners, as well as a rapidly expanding distribution network of well over 5,000 key syndication outlets, to generate greater brand awareness for ORhub. “ORhub is entering into a season of acceleration, and during this time it is important that we keep the investment…

Continue Reading

WednesdayFeb 15, 2017 12:38 pm

NetworkNewsBreaks – TapImmune, Inc. (NASDAQ: TPIV) Receives Positive DSMB Safety Review for TPIV 200, Advances Phase 2 Trial

TapImmune (NASDAQ: TPIV) this morning said it has received a positive recommendation from an independent Data Safety Monitoring Board (DSMB) regarding the company’s lead cancer vaccine candidate, TPIV 200, to continue dosing triple-negative breast cancer (TNBC) patients in an ongoing phase 2 clinical trial. The planned safety review was conducted when enrollment was at 25 percent (20/80 patients). The four-arm trial is designed to test the safety, dosing level and optimal treatment regimen of TPIV 200 against TNBC cells. TapImmune will enroll the remaining patients at 12 clinical centers in the U.S., with enrollment completion targeted for the end of…

Continue Reading

WednesdayFeb 15, 2017 11:49 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 15, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: HIPC 35.71% – News: Moving on the recent launch of Living Gourmet’s raw-vegan line FNCX 28.68% – News: Posts Q2 2017 financial results GRPN 20.63% – News: Posts Q4, full-year 2016 financial results ADHD 11.67% – News: Posts Q4, full-year 2016 financial results GRWG 7.91% – News: Creates $2.5M retail distribution center in California through acquisition of all Sonoma Hydro assets TPIV 4.48% – News: Receives favorable DSMB safety review for TPIV 200, advances…

Continue Reading

WednesdayFeb 15, 2017 11:08 am

NetworkNewsBreaks – Sino-Global (NASDAQ: SINO) Shares Drop on News of $4.77M Registered Direct Offering

Sino-Global (NASDAQ: SINO) shares fell 21% after the company this morning announced that it has entered into definitive agreements with three institutional investors to purchase a total of $4.77 million of its common stock in a registered direct offering at $3.18 per share. The company, a non-asset based global shipping and freight logistic integrated solution provider, estimates that the net proceeds from the offering will be approximately $4.3 million after deducting estimated offering expenses and placement agent fees. Sino-Global will use the net proceeds of the offering for working capital and general corporate purposes. The offering is expected to close on or about February 21, 2017. To view the…

Continue Reading

WednesdayFeb 15, 2017 11:04 am

NetworkNewsBreaks – Qualstar Corp.’s (NASDAQ: QBAK) N2Power Division Receives $1.0M Order; Shares Rise

Shares of Qualstar (NASDAQ: QBAK) rose 14% this morning on news that the company’s N2Power Division has received a $1.0 million order from a significant gaming customer that's expected to ship over the next 12 months. The N2Power Division is engaged in the design and manufacture of compact and highly-efficient power supplies and provides standard, semi-custom and custom power solutions for many original equipment manufacturers (OEM) in various markets. “The inherent advantages of our power solutions provide OEM designers with valuable increased functionality while reducing thermal loads, cooling requirements and lowering operating costs through very high efficiency ratings,” N2Power’s director…

Continue Reading

TuesdayFeb 14, 2017 3:43 pm

NetworkNewsBreaks – GreeneStone Healthcare (GRST) Exits Canadian Addiction Treatment Business, Enters Florida Health Care Market following “Transformational Event”

Health care services provider GreeneStone Healthcare Corporation (OTCQB: GRST) today announced a string of strategic moves designed to strengthen the company’s balance sheet and position it for sustainable growth in the U.S. health care market. First, GreeneStone acquired Cranberry Cove Holdings, which owns the real estate used by GreeneStone’s addiction treatment facility in Muskoka, Ontario. Next, the company sold the operational assets of its Muskoka clinic for a total consideration of CDN$10 million. Through its newly-acquired subsidiary, the company will continue to own and lease the clinic building moving forward. Finally, on February 13, 2017, GreeneStone closed on the acquisition…

Continue Reading

TuesdayFeb 14, 2017 2:53 pm

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Announces Addition of Super Bowl Quarterback Vince Ferragamo to the Agent-Owned Cloud Brokerage®

eXp World Holdings, Inc. (OTCQB: EXPI), holding company for eXp Realty LLC, today announced the addition of real estate veteran and former Los Angeles Rams quarterback Vince Ferragamo to the Agent-Owned Cloud Brokerage®. Ferragamo is most widely-recognized for his tenure in the National Football League, during which he became the first quarterback to start a Super Bowl in the same season as his first career start. Since his retirement from the NFL, Ferragamo has been active in the real estate industry as a brokerage owner. “eXp Realty is exciting to me because the company recognizes and believes as I do…

Continue Reading

TuesdayFeb 14, 2017 12:34 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 14, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ORHB 93.01% – News: Expands pilot program in new hospital BDCI 47.93% – News: Receives formal commitment letter from lender to fund acquisition COYN 27.87% – News: Reports positive outlook for 2017 BASI 18.00% – News: Posts Q1 2017 financial results VPIG 10.60% – News: Prepares beta testing for child-focused payment application MDVX 9.26% – News: Completes financing VKIN 9.00% – News: Enters into LOI to increase its oil production in the Cherokee Basin…

Continue Reading

TuesdayFeb 14, 2017 12:33 pm

NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating, $8 PT on Intellipharmaceutics International, Inc. (NASDAQ: IPCI)

Aegis Capital has reiterated its 'Buy' rating and $8 price target for Intellipharmaceutics International (NASDAQ: IPCI), citing expectations that the company will continue to make progress in 2017. In an earnings release last week, Intellipharmaceutics recapped its achievements in 2016, which included a license and commercial supply agreement with Mallinckrodt LLC to market, sell and distribute several of the company’s extended release drug product candidates (generic Seroquel XR®, generic Pristiq®, generic Lamictal® XR™). Intellipharmaceutics also secured tentative approval for generic Seroquel XR® with official launch planned for first half of 2017. Revenues for full-year 2016 were $2.2 million vs. $4.1…

Continue Reading

Contact us: 212.418.1217